Bundang Rehabilitative Impact Study of the Elbow Epicondylitis

NCT02492945 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Lateral Epicondylitis

Interventions

DRUG: 3ml-Rejuvinex
DRUG: 3ml-15%-dextrose solution

Sponsor

Seoul National University Bundang Hospital